TCL Archive Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards February 12, 1999
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details January 7, 1983
TCL Archive In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology June 28, 1996
